Multi-omic analysis of the tumor microenvironment shows clinical correlations in Ph1 study of atezolizumab +/- SoC in MM

Multiple myeloma (MM) remains incurable, and treatment of relapsed/refractory (R/R) disease is challenging. There is an unmet need for more targeted therapies in this setting; deep cellular and molecular phenotyping of the tumor and microenvironment in MM could help guide such therapies. This phase...

Descripción completa

Detalles Bibliográficos
Autores principales: Wong, Sandy, Hamidi, Habib, Costa, Luciano J., Bekri, Selma, Neparidze, Natalia, Vij, Ravi, Nielsen, Tina G., Raval, Aparna, Sareen, Rajan, Wassner-Fritsch, Elisabeth, Cho, Hearn J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10408441/
https://www.ncbi.nlm.nih.gov/pubmed/37559718
http://dx.doi.org/10.3389/fimmu.2023.1085893

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10408441/
https://www.ncbi.nlm.nih.gov/pubmed/37559718
http://dx.doi.org/10.3389/fimmu.2023.1085893

Ejemplares similares